Chapter 10: New dimensions in cervical cancer screening.

[1]  J. Wardle,et al.  Women's experiences of repeated HPV testing in the context of cervical cancer screening: a qualitative study , 2007, Psycho-oncology.

[2]  J. Berkhof,et al.  Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 18, 31 and 33‐positive women with normal cytology , 2006, International journal of cancer.

[3]  C J L M Meijer,et al.  Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix , 2006, The Journal of pathology.

[4]  S. Ciatto,et al.  Role of P16(INK4a) expression in identifying CIN2 or more severe lesions among HPV‐positive patients referred for colposcopy after abnormal cytology , 2006, Cancer.

[5]  J. Wardle,et al.  Social and psychological impact of HPV testing in cervical screening: a qualitative study , 2006, Sexually Transmitted Infections.

[6]  H. Kitchener,et al.  A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening , 2006, International journal of cancer.

[7]  H. Skomedal,et al.  Human papillomavirus E6/E7 mRNA expression in women younger than 30 years of age. , 2006, Gynecologic oncology.

[8]  M. von Knebel Doeberitz,et al.  Evaluation of a nuclear score for p16INK4a‐stained cervical squamous cells in liquid‐based cytology samples , 2005, Cancer.

[9]  David R. Scott,et al.  The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. , 2005, Journal of the National Cancer Institute.

[10]  C. Wheeler,et al.  Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. , 2005, Journal of the National Cancer Institute.

[11]  J. Fitzgerald,et al.  Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis , 2005, Sexually Transmitted Infections.

[12]  B. King,et al.  p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer , 2005, Journal of Clinical Pathology.

[13]  C. Dalrymple,et al.  p16INK4a as a complementary marker of high‐grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies , 2005, Pathology.

[14]  H. Skomedal,et al.  Comparison of Human Papillomavirus Messenger RNA and DNA Detection: A Cross-sectional Study of 4,136 Women >30 Years of Age with a 2-Year Follow-up of High-Grade Squamous Intraepithelial Lesion , 2005, Cancer Epidemiology Biomarkers & Prevention.

[15]  M. Guo,et al.  The Predictive Value of p16INK4a and Hybrid Capture 2 Human Papillomavirus Testing for High-Grade Cervical Intraepithelial Neoplasia , 2004 .

[16]  A. Schneider,et al.  Detection of cancer‐related gene expression profiles in severe cervical neoplasia , 2004, International journal of cancer.

[17]  S. Moss,et al.  Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study , 2004, BMJ : British Medical Journal.

[18]  M. J. Whitley,et al.  Human papillomavirus type specific DNA and RNA persistence—implications for cervical disease progression and monitoring , 2004, Journal of medical virology.

[19]  T. Nakajima,et al.  Usefulness of liquid‐based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing , 2004, Cancer.

[20]  H. Skomedal,et al.  Human papillomavirus oncogenic expression in the dysplastic portio; an investigation of biopsies from 190 cervical cones , 2004, British Journal of Cancer.

[21]  T. Wright,et al.  Women's desired information about human papillomavirus , 2004, Cancer.

[22]  U Menon,et al.  Management of women who test positive for high-risk types of human papillomavirus: the HART study , 2003, The Lancet.

[23]  H. Lai,et al.  Expression of p16 INK4A in Papanicolaou smears containing atypical squamous cells of undetermined significance from the uterine cervix. , 2003, Gynecologic oncology.

[24]  C. Meijer,et al.  The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity , 2003, The Journal of pathology.

[25]  J. Wardle,et al.  Awareness of human papillomavirus among women attending a well woman clinic , 2003, Sexually transmitted infections.

[26]  J. Wardle,et al.  Attitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani, African-Caribbean and white British women in the UK , 2003, British Journal of Cancer.

[27]  M. V. Doeberitz.  New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. , 2002 .

[28]  B. Thomsen,et al.  Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study , 2002, BMJ : British Medical Journal.

[29]  J. Wardle,et al.  Awareness of risk factors for cancer among British adults. , 2001, Public health.

[30]  D. Stewart,et al.  Knowledge About Human Papillomavirus Among Adolescents , 2000, Obstetrics and gynecology.

[31]  Y. Taketani,et al.  Ubiquitous presence of E6 and E7 transcripts in human papillomavirus—Positive cervical carcinomas regardless of its type , 2000, Journal of medical virology.

[32]  C. Meijer,et al.  Relation of human papilloma virus status to cervical lesions and consequences for cervical-cancer screening: a prospective study , 1999, The Lancet.

[33]  G. Williams,et al.  Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  H. Hausen,et al.  Human papillomaviruses. , 1994, Annual review of microbiology.

[35]  F. Kaye,et al.  Inhibition of cyclin D-CDK 4 / CDK 6 activity is associated with an E 2 F-mediated induction of cyclin kinase inhibitor activity ( human papillomaviruses / cervical cancer / E 7 oncoprotein / retinoblastoma protein ) , 2022 .